1333219-06-9Relevant articles and documents
PHARMACEUTICAL COMPOSITION HAVING FAVORABLE STABILITY
-
, (2022/02/19)
Provided is a medicinal composition having excellent stability, the medicinal composition comprising 3-{[(2S)-2-amino-2-carboxyethyl]carbamoylamino}-5-chloro-4-methylbenzenesulfonic acid, a pharmaceutically acceptable salt thereof, or a solvate thereof, wherein the medicinal composition has a pH of 8.0 or less.
PROPHYLACTIC OR THERAPEUTIC AGENT FOR DIABETES OR OBESITY
-
Paragraph 0149, (2013/03/26)
An object is to provide a CaSR agonist agent that has excellent CaSR agonist effects, and particularly, a pharmaceutical product that can prevent or remedy diabetes or obesity by the effect of CaSR activation. The aforementioned object is achieved by a co